279 related articles for article (PubMed ID: 22433652)
1. Challenges in allogeneic mesenchymal stem cell-mediated cardiac repair.
Dhingra S; Huang XP; Li RK
Trends Cardiovasc Med; 2010 Nov; 20(8):263-8. PubMed ID: 22433652
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.
Huang XP; Sun Z; Miyagi Y; McDonald Kinkaid H; Zhang L; Weisel RD; Li RK
Circulation; 2010 Dec; 122(23):2419-29. PubMed ID: 21098445
[TBL] [Abstract][Full Text] [Related]
3. Preserving prostaglandin E2 level prevents rejection of implanted allogeneic mesenchymal stem cells and restores postinfarction ventricular function.
Dhingra S; Li P; Huang XP; Guo J; Wu J; Mihic A; Li SH; Zang WF; Shen D; Weisel RD; Singal PK; Li RK
Circulation; 2013 Sep; 128(11 Suppl 1):S69-78. PubMed ID: 24030423
[TBL] [Abstract][Full Text] [Related]
4. Cardiac repair with allogeneic mesenchymal stem cells after myocardial infarction.
Vassalli G; Moccetti T
Swiss Med Wkly; 2011; 141():w13209. PubMed ID: 21607881
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells and their potential as cardiac therapeutics.
Pittenger MF; Martin BJ
Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981
[TBL] [Abstract][Full Text] [Related]
6. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
Poncelet AJ; Vercruysse J; Saliez A; Gianello P
Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
[TBL] [Abstract][Full Text] [Related]
7. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
8. Regenerative capacity of intravenous autologous, allogeneic and human mesenchymal stem cells in the infarcted pig myocardium-complicated by myocardial tumor formation.
Wolf D; Reinhard A; Seckinger A; Gross L; Katus HA; Hansen A
Scand Cardiovasc J; 2009 Feb; 43(1):39-45. PubMed ID: 18609048
[TBL] [Abstract][Full Text] [Related]
9. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation.
Duan X; Yang L; Dong S; Xin R; Chen G; Guo L
Arch Orthop Trauma Surg; 2008 Jul; 128(7):751-9. PubMed ID: 18265994
[TBL] [Abstract][Full Text] [Related]
10. Imaging the survival and utility of pre-differentiated allogeneic MSC in ischemic heart.
Xia C; Cao J
Biochem Biophys Res Commun; 2013 Aug; 438(2):382-7. PubMed ID: 23899528
[TBL] [Abstract][Full Text] [Related]
11. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction.
Nassiri SM; Khaki Z; Soleimani M; Ahmadi SH; Jahanzad I; Rabbani S; Sahebjam M; Ardalan FA; Fathollahi MS
J Biomed Sci; 2007 Nov; 14(6):745-55. PubMed ID: 17605008
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects.
Dai W; Hale SL; Martin BJ; Kuang JQ; Dow JS; Wold LE; Kloner RA
Circulation; 2005 Jul; 112(2):214-23. PubMed ID: 15998673
[TBL] [Abstract][Full Text] [Related]
13. Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart.
Huang XP; Ludke A; Dhingra S; Guo J; Sun Z; Zhang L; Weisel RD; Li RK
FASEB J; 2016 Sep; 30(9):3069-82. PubMed ID: 27221978
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic Mesenchymal Stromal Cells Transplanted Onto the Heart Surface Achieve Therapeutic Myocardial Repair Despite Immunologic Responses in Rats.
Tano N; Kaneko M; Ichihara Y; Ikebe C; Coppen SR; Shiraishi M; Shintani Y; Yashiro K; Warrens A; Suzuki K
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26896478
[TBL] [Abstract][Full Text] [Related]
15. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
[TBL] [Abstract][Full Text] [Related]
16. A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart.
Furlani D; Li W; Pittermann E; Klopsch C; Wang L; Knopp A; Jungebluth P; Thedinga E; Havenstein C; Westien I; Ugurlucan M; Li RK; Ma N; Steinhoff G
Cell Transplant; 2009; 18(3):319-31. PubMed ID: 19558780
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells for cardiac regenerative therapy.
Schuleri KH; Boyle AJ; Hare JM
Handb Exp Pharmacol; 2007; (180):195-218. PubMed ID: 17554510
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction.
Cai A; Zheng D; Dong Y; Qiu R; Huang Y; Song Y; Jiang Z; Rao S; Liao X; Kuang J; Dai G; Mai W
Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):857-66. PubMed ID: 21983658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
